Table 4.
Insulin adverse change (AC) rates. Interactions with baseline characteristics.
| Control | Exercise | Interaction p-value | |
|---|---|---|---|
|
| |||
| Agea: AC | 53 (35–64) | 53 (44–63) | 0.85 |
| Non-AC | 54 (41–66) | 54 (45–64) | |
|
| |||
| Gender: | 0.92 | ||
| AC female | 11.4% | 7.7% | |
| AC male | 16.0% | 7.8% | |
|
| |||
| Race/ethnicity: | 0.76 | ||
| AC Caucasian | 12.0% | 6.5% | |
| AC Afr-Amer | 15.0% | 12.6% | |
| AC Hispanic/other | 13.6% | 5.7% | |
|
| |||
| BMI: AC | 32 (26–37) | 32 (28–36) | 0.56 |
| Non-AC | 30 (25–38) | 30 (25–36) | |
|
| |||
| Peak VO2: AC | 17.9 (12.8–33.4) | 16.8 (12.7–33.5) | 0.95 |
| Non-AC | 21.0 (13.4–33.7) | 19.2 (12.9–34.0) | |
Continuous variables are reported as: median (10th percentile, 90th percentile)